CoChat

Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Purpose: We tested the hypotheses that Src tyrosine kinase overactivity represents a chemoresistance mechanism and that Src inhibition may enhance gemcitabine cytotoxicity in pancreatic adenocarcinoma cells. Experimental Design: Pancreatic adenocarcinoma cells PANC1, MiaPaCa2, Capan2, BxPC3, and PANC1GemRes, a stably gemcitabine-resistant subline of PANC1, were exposed to combinations of gemcitabine and Src tyrosine kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). Src expression, phosphorylation (Tyr-416), and activity were analyzed by immunoblotting and in vitro kinase assay. Expression of the M2 subunit of ribonucleotide reductase (RRM2), a putative chemoresistance enzyme, was quantified by Northern and Western blot. Cellular proliferation was quantified by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Apoptosis was characterized by YO-PRO-1/propidium iodide staining, fluorometric caspase profiling, and caspase inhibition (Z-Val-Ala-Asp-fluoromethyl ketone). The effects of constitutively active and dominant negative Src were determined. The therapeutic efficacy of PP2 in combination with gemcitabine was tested in nude mice orthotopically xenografted with PANC1GemRes. Results: Greater gemcitabine resistance was associated with higher Src phosphorylation and activity, both of which were higher in PANC1GemRes, relative to PANC1; total Src levels were alike. PANC1GemRes overexpressed RRM2. PP2 enhanced inherent gemcitabine chemosensitivity and attenuated gemcitabine resistance in PANC1GemRes. Constitutively active Src increased gemcitabine chemoresistance; dominant negative Src impaired gemcitabine chemoresistance. PP2 augmented gemcitabine-induced caspase-mediated apoptosis, suppressed RRM2 expression, and decreased activity of the RRM2-regulating transcription factor E2F1 in PANC1GemRes. PP2 and gemcitabine in combination substantially decreased tumor growth and inhibited metastasis in vivo. Conclusions: Increased Src tyrosine kinase activity represents a potential chemoresistance mechanism and a promising therapeutic target warranting further investigation in gemcitabine-resistant pancreatic adenocarcinoma.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-1183-3

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 60 references

Cited by

See all 192

Metadata

Authors
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E.
Affiliations
Brigham and Women's Hospital (US)
Venue
Clinical Cancer Research
Published
2004-04-01
Volume
10
Issue
7
Pages
2307-2318
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2117844134
Cited by
192
References
60
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 11 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 9 · 2018: 2 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 6 · 2012: 16
FWCI
6.40
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords
Src kinase, gemcitabine resistance, pancreatic ductal adenocarcinoma, PP2, RRM2, ribonucleotide reductase, E2F1, caspase-dependent apoptosis, chemosensitization, combination chemotherapy, metastasis, Src phosphorylation, tumor xenografts, metastatic pancreatic cancer
MeSH terms
Gemcitabine, Adenocarcinoma, Animals, Antimetabolites, Antineoplastic, Antineoplastic Agents, Cell Division, Cell Nucleus, Deoxycytidine, DNA-Binding Proteins, Dose-Response Relationship, Drug, Genes, Dominant, Humans, Mice, Nude, Neoplasm Metastasis, Neoplasm Transplantation, Pancreatic Neoplasms, Phosphorylation, Pyrimidines, Ribonucleoside Diphosphate Reductase, Transcription Factors, Tyrosine, Blotting, Northern, Blotting, Western, Apoptosis, Cell Cycle Proteins, Drug Resistance, Neoplasm, src-Family Kinases, Inhibitory Concentration 50, Caspases, Cell Line, Tumor, E2F Transcription Factors, E2F1 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-1183-3
The paper
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004). Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-1183-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.